Financials
Financial year 2025
Worth noting
- Little cash and receivables against the short-term debts.
Revenue
€ 532.8 million
▲ 12% vs 2024
Profit
Healthy€ 551,113
▼ 57% vs 2024
Debts
High€ 165.8 million
▼ 1% vs 2024
SUMITOMO CHEMICAL EUROPE S.A./N.V. from Zaventem, company number BE0453622676, closed financial year 2025 with a result of € 551,113 after tax. For that financial year SUMITOMO CHEMICAL EUROPE S.A./N.V. recorded revenue of € 532.8 million and equity of € 24.4 million. Compared with financial year 2024, the result moved from € 1.3 million to € 551,113. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2025.
What happened at SUMITOMO CHEMICAL EUROPE S.A./N.V.?
What happened at SUMITOMO CHEMICAL EUROPE S.A./N.V. in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 551,113 (▼ 57% vs 2024). Source: NBB ↗
- Saito SHIGENORI stepped down as director. NBB
- Jun KATAOKA stepped down as director. NBB
- Hiroyuki MIURA stepped down as director. NBB
- Nozomu MASUYAMA stepped down as director. NBB
- Dirk GEERINCK stepped down as director. NBB
- Saito SHIGENORI became a director. NBB
- Jun KATAOKA became a director. NBB
In short
From € 6.8 million profit in 2022 to € 551,113 profit in 2025.
Paid € 4.4 million in corporate taxes since 2022.
Best year ever: 2022, with € 6.8 million profit.
Paid out € 5.5 million in dividends to the owners in total.
A new publication or filing at SUMITOMO CHEMICAL EUROPE S.A./N.V.? We notify you, reason included.
Follow SUMITOMO CHEMICAL EUROPE S.A./N.V.Need more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by Sumitomo Chemical Co, Ltd (99.9%) and Sumitomo Chemical (UK) Plc (0.1%). It owns 50% of Sumitomo Chemical Turkey itself.
Directors
According to the 2025 annual accounts
Saito SHIGENORI
Director
since 2024 · until 2025
Jun KATAOKA
Managing director
since 2024 · until 2025
Hiroyuki MIURA
Director
since 2024 · until 2025
Nozomu MASUYAMA
Director
since 2024 · until 2025
Dirk GEERINCK
Director
since 2024 · until 2025
Shareholders
Sumitomo Chemical Co, Ltd
99.9%
Sumitomo Chemical (UK) Plc
0.1%
Participations
Sumitomo Chemical Turkey
50%
Establishments
Establishment units
Physical locations of this company
Hermeslaan 11
1932 Zaventem
Diegemstraat 9
1800 Vilvoorde
Active since 1 January 2023
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 17 companies are registered at this address.
L'Air liquide Belge
€ 126.7 million revenue · 2025
HYDROWAL
€ 1.8 million revenue · 2025
AIR LIQUIDE MEDICAL
€ 33.6 million revenue · 2025
AIR LIQUIDE INDUSTRIES BELGIUM
€ 573.8 million revenue · 2025
Moore Corporate Finance
€ 7.4 million revenue · 2025
+12 more
Details
- Company number
- 0453.622.676
- VAT number
- BE 0453.622.676
- Registered office
- Hermeslaan 11, 1932 Zaventem
- Names & denominations
- SUMITOMO CHEMICAL EUROPE S.A./N.V.
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 28 October 1994
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Groothandel in chemische producten voor industrieel gebruik
Groothandel in chemische producten
Vervaardiging van kleurstoffen en pigmenten
Groothandel in andere intermediaire producten, neg
Groothandel in andere intermediaire producten, n.e.g.